Applied dna provides business update on covid-19 diagnostics and testing

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq:apdn) (the “company”), a leader in polymerase chain reaction (pcr)-based dna manufacturing, today announced that its safecircle™ pooled surveillance testing service has seen a 158% increase in the daily average number of tests performed to date in january 2021 compared to december 2020. the increase is chiefly the result of the scale-up of certain testing contracts and from the acquisition of new clients. launched in the fou
APDN Ratings Summary
APDN Quant Ranking